21.19
Schlusskurs vom Vortag:
$23.37
Offen:
$22.77
24-Stunden-Volumen:
3.49M
Relative Volume:
2.32
Marktkapitalisierung:
$1.99B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
33.63
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
-8.78%
1M Leistung:
-6.07%
6M Leistung:
+27.57%
1J Leistung:
-34.80%
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PGNY
Progyny Inc
|
21.19 | 1.99B | 1.13B | 62.75M | 170.92M | 0.63 |
![]()
UNH
Unitedhealth Group Inc
|
380.64 | 364.02B | 410.06B | 22.11B | 24.86B | 23.88 |
![]()
ELV
Elevance Health Inc
|
404.58 | 92.63B | 183.12B | 5.92B | 3.67B | 25.63 |
![]()
CI
Cigna Group
|
333.46 | 89.43B | 254.47B | 5.03B | 6.01B | 18.06 |
![]()
CVS
Cvs Health Corp
|
66.97 | 85.34B | 378.96B | 5.28B | 5.94B | 4.19 |
![]()
HUM
Humana Inc
|
249.53 | 31.20B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
2024-11-13 | Herabstufung | Truist | Buy → Hold |
2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
2024-01-03 | Eingeleitet | Barclays | Overweight |
2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
2023-05-22 | Eingeleitet | BTIG Research | Buy |
2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2022-09-07 | Eingeleitet | Truist | Buy |
2021-12-02 | Eingeleitet | Jefferies | Buy |
2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
2021-09-30 | Eingeleitet | Berenberg | Buy |
2021-08-12 | Eingeleitet | Barclays | Overweight |
2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
2020-06-02 | Eingeleitet | Guggenheim | Buy |
2019-11-19 | Eingeleitet | Citigroup | Buy |
2019-11-19 | Eingeleitet | Goldman | Buy |
2019-11-19 | Eingeleitet | JP Morgan | Overweight |
2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Progyny, Inc. (NASDAQ:PGNY) Q1 2025 Earnings Call Transcript - Insider Monkey
Decoding Progyny Inc (PGNY): A Strategic SWOT Insight - GuruFocus
Progyny, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
PGNY Q1 Earnings Call: Product Expansion, Member Growth, and Guidance Raised - Yahoo Finance
Earnings call transcript: Progyny Q1 2025 beats EPS estimates By Investing.com - Investing.com India
Progyny, Inc. Reports Strong Q1 2025 Results - TipRanks
Progyny Inc (PGNY) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions - Yahoo Finance
Progyny, Inc. (PGNY) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - ACCESS Newswire
Earnings call transcript: Progyny Q1 2025 beats EPS estimates - Investing.com
Progyny: Q1 Earnings Snapshot - Norwalk Hour
Progyny Q1 2025 Earnings Call Transcript - MarketBeat
Progyny, Inc. Announces First Quarter 2025 Results - GlobeNewswire
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Progyny Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Progyny, Inc. Q1 Profit Beats Estimates - Nasdaq
Progyny (PGNY) Surpasses Q1 Revenue Expectations with Robust Growth | PGNY Stock News - GuruFocus
Progyny (NASDAQ:PGNY) Posts Better-Than-Expected Sales In Q1, Provides Optimistic Revenue Guidance for Next Quarter - Yahoo Finance
(PGNY) PROGYNY INC. Forecasts Q2 Revenue Range $310M$325M - marketscreener.com
Progyny Inc (PGNY) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Progyny (PGNY) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
BlackRock, Inc. Adjusts Holdings in Progyny Inc: A Strategic Portfolio Move - GuruFocus
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building - ADVFN
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Progyny: Q3 Earnings Snapshot - marketscreener.com
At US$22.90, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely? - simplywall.st
Progyny, Inc. Announces Details for Its First Quarter 2025 Resul - GuruFocus
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report - The Manila Times
Progyny, Inc. to Report Q1 2025 Financial Results on May 8, 2025 - Nasdaq
Progyny Sets Date for Q1 2025 Earnings: What Fertility Healthcare Investors Should Watch - Stock Titan
(PGNY) Technical Data - news.stocktradersdaily.com
Why Progyny (PGNY) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Progyny Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Progyny Rings the Opening Bell - Nasdaq
Progyny names Melissa Cummings as COO - MSN
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY) - Yahoo Finance
Progyny (PGNY) Boosts Leadership Team with COO and Chief Product - GuruFocus
Progyny names new COO and CPO to drive growth By Investing.com - Investing.com India
Progyny Names Melissa Cummings COO - marketscreener.com
Progyny names new COO and CPO to drive growth - Investing.com
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer | PGNY Stock News - GuruFocus
Progyny Names Healthcare Veterans Melissa Cummings as Chief - GlobeNewswire
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer - TradingView
Progyny to Host Events Honoring Individuals, Families and Infert - GuruFocus
Progyny to Host Events Honoring Individuals, Families and - GlobeNewswire
Progyny Takes Over Nasdaq & Empire State Building for Groundbreaking Fertility Awareness Week - Stock Titan
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week® | PGNY Stock News - GuruFocus
Progyny announces director Dr. Fred Cohen to step down By Investing.com - Investing.com Canada
Form DEFA14A Progyny, Inc. - StreetInsider
Progyny announces director Dr. Fred Cohen to step down - Investing.com Australia
Progyny Director Fred Cohen to Step Down - TipRanks
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):